St Clair, E William <br/><br/>
Rituximab therapy for primary Sjögren's syndrome: an open-label clinical trial and mechanistic analysis.  [electronic resource] 

 -  Arthritis and rheumatism  Apr 2013 
 - 1097-106 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1529-0131 
<br/><br/><label>Standard No.: </label>10.1002/art.37850  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Antibodies, Monoclonal, Murine-Derived--adverse effects<br/>Autoantibodies--blood<br/>B-Lymphocytes--cytology<br/>Female<br/>Flow Cytometry<br/>Humans<br/>Immunologic Factors--adverse effects<br/>Lymphocyte Count<br/>Middle Aged<br/>Prospective Studies<br/>Rituximab<br/>Sjogren's Syndrome--blood<br/>Treatment Outcome